- Legislation Introduced to Codify Stem Cell Rules
- Commissioner Enhances FDA’s Commitment to Personalized Medicine
- Perfecting Policy on Stem Cells
- NIH and FDA Aim to Retool Regulatory Science
- DOE Leads Federal Funding for a Regional Innovation Cluster
- Certainty on the Science of Climate Change
- They’re Not Perfect Cells, But They’re Model Cells
- Genomic Medicine on the March
- President’s Budget Aims to Recharge Regional Innovation
- Event: The Science of Climate Change
- Progress in Bioethics
- The Top Science Progress Features of 2009
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
Dispatches from the Many Fronts of the Stem Cell Wars
Stem cells in a lab at the University of Georgia.
Source: AP.
No new stem cell funding will be included in the Labor-HHS-Education appropriations bill (S.1710). CQ reports (subscription) that Senator Tom Harkin (D-IA) promptly offered an amendment removing language that he and Senator Arlen Specter (D-PA) had previously inserted to expand funding for stem cell research. There was no vote, only a removal.
This language would have allowed funding for stem cell lines created after June 15, 2007, thereby overriding the President’s executive order in which he limited federal funding for stem cell research to cell lines created before August 9, 2001.
This comes in the wake of President Bush’s veto threat which mentions the bill’s stem cell provision on its first page before it even begins to enumerate multiple other quibbles.
In other stem cell news, MedlinePlus reports that, according to a paper in the journal Cell: Stem Cell, the Oct4 protein which maintains pluripotency in embryonic stem cells is not present in adult stem cells as was previously claimed in more than 50 studies. This means that there may be many adult stems cell lines that are not as useful for research purposes as originally thought.
In spite of these federal restrictions, the states are making efforts to move ahead and fund stem cells research themselves. The Detroit News reports that shopping mall magnate A. Alfred Taubman has donated $1.4 million to Michigan Stem Cell Research & Cures which aims to educate the public about the state’s restrictive laws on stem cell research. Taubman has also promised to be a major donor if a ballot campaign goes forward for November 2008. Key quote from Taubman: “I’ve known people who I’ve seen die. Had embryonic stem cell research been around, I believe they’d be alive today.”
Comments on this article
